Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out
March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Saturday, July 12, 2008

What are probiotics?

In his book, the editor, Roy Fuller stresses the need for a probiotic to be viable when he redefines probiotics in 1989 as "A live microbial feed supplement which beneficially affects the host animal by improving its intestinal microbial balance." Not all probiotic products in the market are viable by the time they reach the shelves, and thus do not have the same potency and desired effects.

Fuller goes on to list the wide range of lactobacilli generally used in probiotics , "Currently available probiotic preparations contain L. delbreuckii subsp. bugaricus, L. acidophilus, L. casei, L. fermentum. L. plantarum, L. brevis, L. cellobiosus, L. lactis and L. reuteri."

In 1905, Tissier showed that bifidobacteria were the dominant bacteria in the gut of brest-fed infants, and from his work stems the use of bifidobacteria used as probiotics, which are, "Bifidobacterium adolescentis, Bif. animalis, Bif. bifidum, Bif. infantis, Bif. longum, and Bif. thermophilum."

In sour milk and yogurts we find the first use of streptococci as probiotics, with the yogurt starter S. salivarius subsp. thermophilus currently being a common probiotic organism.

Book: Fuller, R. (Ed.). (1992). Probiotics, The scientific basis. London: Chapman & Hall.


Post a Comment